Bartosz Hudzik
Latest contributions
New insights into pharmacological treatment for STEMI
21 May 2026 – From EuroPCR 2026
This session presents the latest pharmacological advances in the treatment of ST-segment elevation myocardial infarction (STEMI). It covers safety data on ticagrelor monotherapy post-primary PCI, the impact of P2Y12 inhibitor pretreatment, effects of dapagliflozin on myocardial remodeling, and considerations for bleeding risk and vascular preparation strategies...
Risk and prognosis predictors in STEMI
21 May 2026 – From EuroPCR 2026
This session explores key risk and prognostic factors in ST-elevation myocardial infarction (STEMI), encompassing biomarker-based outcome prediction, the influence of low-density lipoprotein cholesterol on myocardial injury, and thrombotic risk in atrial fibrillation patients undergoing PCI. It further examines gender differences in young STEMI patients, the safety...
Complex interventions in challenging STEMI
19 May 2023 – From EuroPCR 2023
Discover a selection of challenging STEMI cases that push the boundaries of interventional cardiology: witness the unique predicament of synchronous AMI and ischemic stroke, learn about the ingenious CTO techniques that come to the rescue in critical situations, tackle the complexities of acute left main stem...
